{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:45:54Z","timestamp":1788306354332,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100017577","name":"Basic Public Welfare Research Program of Zhejiang Province","doi-asserted-by":"publisher","award":["LGF19H100002"],"award-info":[{"award-number":["LGF19H100002"]}],"id":[{"id":"10.13039\/501100017577","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.jpeds.2021.02.008","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T20:35:58Z","timestamp":1612989358000},"page":"203-211.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Sudden Hypotension and Increased Serum Interferon-\u03b3 and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis"],"prefix":"10.1016","volume":"235","author":[{"given":"Li","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9603-3939","authenticated-orcid":false,"given":"Yiping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0733-8031","authenticated-orcid":false,"given":"Xubo","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongjun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Teng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence Kwok","family":"Leung Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2021.02.008_bib1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0022-3476(96)70140-3","article-title":"Macrophage activation syndrome in systemic juvenile rheumatoid arthritis","volume":"129","author":"Grom","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2021.02.008_bib2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.jpeds.2021.02.008_bib3","series-title":"Pediatric rheumatology","first-page":"55","article-title":"Macrophage activation syndrome","author":"Ravelli","year":"2008"},{"key":"10.1016\/j.jpeds.2021.02.008_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2147\/OARRR.S151013","article-title":"Macrophage activation syndrome: early diagnosis is key","volume":"31","author":"Lerkvaleekul","year":"2018","journal-title":"Open Access Rheumatol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/00002281-200309000-00011","article-title":"Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities?","volume":"15","author":"Grom","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1136\/annrheumdis-2015-208982","volume":"75","author":"Ravelli","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jpeds.2021.02.008_bib7","first-page":"1133","article-title":"Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis","volume":"34","author":"Behrens","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib8","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1002\/art.22416","article-title":"The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor \u03b1-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis","volume":"56","author":"Bleesing","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpeds.2021.02.008_bib9","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/rheumatology\/40.11.1285","article-title":"Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients","volume":"40","author":"St\u00e9phan","year":"2001","journal-title":"Rheumatology"},{"key":"10.1016\/j.jpeds.2021.02.008_bib10","doi-asserted-by":"crossref","first-page":"4135","DOI":"10.1002\/art.34661","article-title":"Macrophage activation syndrome in children with systemic lupus erythematosus and children with juvenile idiopathic arthritis","volume":"64","author":"Bennett","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpeds.2021.02.008_bib11","doi-asserted-by":"crossref","first-page":"e000161","DOI":"10.1136\/rmdopen-2015-000161","article-title":"Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"2","author":"Ravelli","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.jpeds.2021.02.008_bib12","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1002\/art.38802","article-title":"Clinical features, treatment, and outcome of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a multinational, multicenter study of 362 patients","volume":"66","author":"Minoia","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib13","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3899\/jrheum.141261","article-title":"Dissecting the heterogeneity of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"42","author":"Minoia","year":"2015","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar3843","article-title":"Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis","volume":"14","author":"Bode","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jpeds.2021.02.008_bib15","first-page":"197","article-title":"Hemophagocytic lymphohistiocytosis: report of 122 children from the International Registry","volume":"10","author":"Aric\u00f2","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.jpeds.2021.02.008_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1309\/AJCPMD5TJEFOOVBW","article-title":"Marrow assessment for hemophagocytic lymphohistiocytosis demonstrates poor correlation with disease probability","volume":"141","author":"Ho","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib17","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jpeds.2004.12.016","article-title":"Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"146","author":"Ravelli","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2021.02.008_bib18","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1136\/annrheumdis-2019-215211","article-title":"Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"78","author":"Minoia","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jpeds.2021.02.008_bib19","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/1744666X.2015.1058159","article-title":"Clinical features and correct diagnosis of macrophage activation syndrome","volume":"11","author":"Cron","year":"2015","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib20","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/acr.23482","article-title":"Validation of classification criteria of macrophage activation syndrome in Japanese patients with systemic juvenile idiopathic arthritis","volume":"70","author":"Shimizu","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jpeds.2021.02.008_bib21","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib22","series-title":"Pediatric advanced life support provider manual","author":"Ralston","year":"2006"},{"key":"10.1016\/j.jpeds.2021.02.008_bib23","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1093\/ndt\/gfs375","article-title":"A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathy","volume":"27","author":"Fliser","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jpeds.2021.02.008_bib24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/gene.2012.3","article-title":"Macrophage activation syndrome as part of systemic juvenile idiopathic arthritis: diagnosis, genetics, pathophysiology and treatment","volume":"13","author":"Ravelli","year":"2012","journal-title":"Genes Immun"},{"key":"10.1016\/j.jpeds.2021.02.008_bib25","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1002\/art.38769","article-title":"Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile arthritis","volume":"66","author":"Dav\u00ec","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12098-015-1877-1","article-title":"Macrophage activation syndrome","volume":"83","author":"Sen","year":"2016","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.jpeds.2021.02.008_bib27","doi-asserted-by":"crossref","first-page":"5942","DOI":"10.1172\/JCI141113","article-title":"Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children","volume":"130","author":"Lee","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpeds.2021.02.008_bib28","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMoa2021680","article-title":"Multisystem inflammatory syndrome in U.S. children and adolescents","volume":"383","author":"Feldstein","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2021.02.008_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa2021756","article-title":"Multisystem inflammatory syndrome in children in New York state","volume":"383","author":"Dufort","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jpeds.2021.02.008_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/acr2.11048","article-title":"Ferritin to erythrocyte sedimentation rate ratio: simple measure to identify macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"1","author":"Eloseily","year":"2019","journal-title":"ACR Open Rheumatol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","article-title":"Pathogenesis of macrophage activation syndrome and potential for cytokine-directed therapies","volume":"66","author":"Schulert","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jpeds.2021.02.008_bib32","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jpeds.2005.12.070","article-title":"Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood","volume":"148","author":"Avcin","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2021.02.008_bib33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"Crayne","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib34","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/art.39295","article-title":"Inhibition of natural killer cell cytotoxicity by interleukin-6: implications for the pathogenesis of macrophage activation syndrome","volume":"67","author":"Cifaldi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib35","first-page":"1241","article-title":"Serum cytokine levels in children with newly diagnosed active systemic juvenile idiopathic arthritis","volume":"16","author":"Guo","year":"2014","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.jpeds.2021.02.008_bib36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.autrev.2009.01.012","article-title":"Interleukin-6 as a key player in systemic inflammation and joint destruction","volume":"8","author":"Fonseca","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jpeds.2021.02.008_bib37","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1002\/art.22981","article-title":"Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome","volume":"56","author":"Fall","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpeds.2021.02.008_bib38","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1002\/art.34604","article-title":"The limited role of interferon-gamma in systemic juvenile idiopathic arthritis cannot be explained by cellular hyporesponsiveness","volume":"64","author":"Sikora","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jpeds.2021.02.008_bib39","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","article-title":"Elevated circulating levels of interferon-\u03b3 and interferon-\u03b3 induced chemokines characterize patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis","volume":"76","author":"Bracaglia","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jpeds.2021.02.008_bib40","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1172\/JCI43157","article-title":"Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice","volume":"121","author":"Behrens","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpeds.2021.02.008_bib41","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3899\/jrheum.100996","article-title":"An international consensus survey of diagnostic criteria for macrophage activation syndrome in systemic juvenile idiopathic arthritis","volume":"38","author":"Davi","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib42","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2021.02.008_bib43","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jpeds.2021.02.008_bib44","first-page":"685","article-title":"Diagnostic significance of Th1\/Th2 cytokine pattern in childhood hemophagocytic lymphohistiocytosis","volume":"49","author":"Xu","year":"2011","journal-title":"Zhong hua Er Ke Za Zhi"},{"key":"10.1016\/j.jpeds.2021.02.008_bib45","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/j.1365-2141.2008.07298.x","article-title":"Early diagnostic and prognostic significance of a specific Th1\/Th2 cytokine pattern in children with haemophagocytic syndrome","volume":"143","author":"Tang","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib46","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/art.40683","article-title":"Interferon-gamma-mediated immunopathology potentiated by Toll-like receptor 9 activation in a murine model of macrophage activation syndrome","volume":"71","author":"Weaver","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib47","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jaci.2017.07.021","article-title":"Neutralization of IFN-gamma reverts clinical and laboratory features in a mouse model of macrophage activation syndrome","volume":"141","author":"Prencipe","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1182\/blood.2019000761","article-title":"Mechanisms of action of ruxolitinib in murine models of hemophagocytic lymphohistiocytosis","volume":"134","author":"Albeituni","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2021.02.008_bib49","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","article-title":"Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: an open-label, single-centre, pilot trial","volume":"6","author":"Ahmed","year":"2019","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib50","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1182\/blood.2019002289","article-title":"Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis","volume":"134","author":"Vallurupalli","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jpeds.2021.02.008_bib51","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.immuni.2019.03.020","article-title":"IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation","volume":"50","author":"Ouyang","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.jpeds.2021.02.008_bib52","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S1471-4906(03)00181-9","article-title":"Heme oxygenase-1: unleashing the protective properties of heme","volume":"24","author":"Otterbein","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib53","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.imbio.2010.05.020","article-title":"Heme oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release","volume":"215","author":"Sierra-Filardi","year":"2010","journal-title":"Immunobiology"},{"key":"10.1016\/j.jpeds.2021.02.008_bib54","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/JLB.2A0317-107R","article-title":"MicroRNA networks associated with active systemic juvenile idiopathic arthritis regulate CD163 expression and anti-inflammatory functions in macrophages through two distinct mechanisms","volume":"103","author":"Do","year":"2018","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12969-018-0303-4","article-title":"Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL10 and IFN-\u03b3 as biomarkers for early recognition","volume":"17","author":"Li","year":"2019","journal-title":"Pediatr Rheumatol"},{"key":"10.1016\/j.jpeds.2021.02.008_bib56","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jpeds.2021.02.008_bib57","doi-asserted-by":"crossref","first-page":"154481","DOI":"10.1016\/j.cyto.2018.07.012","article-title":"Cytokines and CD8 T cell immunity during respiratory syncytial virus infection","volume":"133","author":"Schmidt","year":"2020","journal-title":"Cytokines"},{"key":"10.1016\/j.jpeds.2021.02.008_bib58","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/rheumatology\/kez282","article-title":"IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome","volume":"59","author":"Yasin","year":"2020","journal-title":"Rheumatology (Oxford)"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347621001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347621001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:10:48Z","timestamp":1758359448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347621001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":58,"alternative-id":["S0022347621001177"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2021.02.008","relation":{},"ISSN":["0022-3476"],"issn-type":[{"value":"0022-3476","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sudden Hypotension and Increased Serum Interferon-\u03b3 and Interleukin-10 Predict Early Macrophage Activation Syndrome in Patients with Systemic Juvenile Idiopathic Arthritis","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2021.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}